Sign in to continue:

Friday, February 20th, 2026

Author: minichart

SGX corporate News

Lum Chang Holdings Announces Joint Ventures, Subsidiary Changes, and Divestments for 1HFY2026 123

minichart
February 12, 2026

Lum Chang Holdings Limited: Key Financial Period Transactions and Updates Lum Chang Holdings Limited: Detailed Review of Key Transactions for 1HFY2026 Overview Lum Chang Holdings Limited has announced a series of significant corporate developments...

Continue Reading 0
SGX corporate News

Nanyang New Development Limited EGM 2026: Key Resolutions on Business Diversification, Name Change, and Constitution Adoption

minichart
February 12, 2026

Nanyang New Development Limited EGM: Key Highlights and Investor Implications Nanyang New Development Limited EGM: Key Highlights and Investor Implications Introduction Nanyang New Development Limited (formerly Matex International Limited) convened an Extraordinary General Meeting...

Continue Reading 0
SGX corporate News

Mary Chia Holdings Announces Termination of Hong Kong Joint Venture and Full Acquisition of Subsidiary

minichart
February 12, 2026

Mary Chia Holdings Limited – Termination of Hong Kong Joint Venture and Share Transfer Mary Chia Holdings Limited Announces Termination of Hong Kong Joint Venture and Acquisition of Full Ownership Key Points for Investors...

Continue Reading 0
SGX corporate News

Prudential plc Announces Share Acquisitions by Senior Executives Under Employee Share Purchase Plan

minichart
February 12, 2026

html Prudential plc: Notification and Public Disclosure of Share Transactions by Senior Management Prudential plc, the international life and health insurance and asset management giant, has made a significant regulatory disclosure regarding share transactions...

Continue Reading 0
SGX corporate News

USP Group Limited Scheme of Arrangement: Creditors Meeting Notice and Key Dates (April 2026)

minichart
February 12, 2026

html USP Group Limited: Notice of Creditors’ Meeting for Proposed Scheme of Arrangement USP Group Limited Issues Notice of Creditors’ Meeting for Proposed Scheme of Arrangement Key Highlights for Investors USP Group Limited (Under...

Continue Reading 0
SGX corporate News

Coliwoo Holdings Included in MSCI Global Micro Cap Indexes Singapore, Boosts Investor Visibility and Growth Potential 1

minichart
February 12, 2026

Coliwoo Holdings Included in MSCI Global Micro Cap Indexes – Singapore Coliwoo Holdings Limited to Join MSCI Global Micro Cap Indexes – Singapore: A Significant Milestone for Investors Key Highlights Coliwoo Holdings Limited (SGX:...

Continue Reading 0
SGX corporate News

BRC Asia Limited Q1 2026 Business Update: Strong Financials Amid Robust Singapore Construction Sector Growth 123

minichart
February 12, 2026

BRC Asia Limited 1Q2026 Business Update: Key Insights for Investors BRC Asia Limited 1Q2026 Business Update: Key Insights for Investors Financial Highlights Revenue: S\$444.3 million for 1Q2026, reflecting robust demand and sustained sales momentum....

Continue Reading 0
SGX corporate News

U.S. Government Awards iX Biopharma $41M Contract to Develop Wafermine® Ketamine Wafer for Military Pain Relief

minichart
February 12, 2026

iX Biopharma Secures US\$41 Million U.S. Government Contract for Wafermine® Development iX Biopharma Awarded US\$41 Million U.S. Defense Contract to Advance Wafermine® for Acute Pain Treatment Key Highlights iX Biopharma Ltd has secured a...

Continue Reading 0
SGX corporate News

iX Biopharma Awarded US$41 Million U.S. Defense Contract for Development of Non-Opioid Sublingual Ketamine Pain Treatment Wafermine® 1

minichart
February 12, 2026

iX Biopharma Awarded US\$41 Million U.S. Government Contract iX Biopharma Secures US\$41 Million U.S. Department of Defense Contract for Non-Opioid Pain Treatment: A Potential Game-Changer for Shareholders Key Highlights iX Biopharma Ltd (SGX: 42C),...

Continue Reading 0
SGX corporate News

iX Biopharma Announces S$6 Million Share Placement to Fund U.S. Government Contract Execution

minichart
February 12, 2026

html iX Biopharma Announces S\$6 Million Placement to Fund U.S. Government Contract iX Biopharma Announces S\$6 Million Placement to Fund U.S. Government Contract Key Points and Investor Highlights Proposed Placement: iX Biopharma Ltd. has...

Continue Reading 0